慧翰股份(301600.SZ):是國內少數同時獲得歐盟eCall認證、聯合國歐洲經濟委員會UN-R144標準認證、阿聯酋eCall認證的供應商
格隆匯9月12日丨慧翰股份(301600.SZ)在投資者互動平台表示,公司是國內少數同時獲得歐盟eCall認證、聯合國歐洲經濟委員會UN-R144標準認證、阿聯酋eCall認證的供應商,已先後為上汽集團、奇瑞汽車、吉利汽車、長城汽車、比亞迪、蔚來汽車等本土自主品牌整車出口歐盟、英國、日本等海外市場提供eCall終端,助力自主品牌車企的國際化發展進程。 目前,歐盟要求標配新一代eCall終端。美國並非緊急呼叫系統強制認證國家,我國對美國的電動汽車出口量較少,所以不是每一台出口歐美的汽車必須裝配eCall產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.